Medicare Fracture Prevention and Osteoporosis Testing Act of 2009

H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R. 3590 (111-148); H.R. 4872 (PL-111-152); H.R. 3962;

Client expense: $60,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 H.R. 4190, S. 2828 Endocrine Disruptor Screening Enhancement Act of 2010 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S. 3209, Safe Chemicals Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1548 - Pathway for Biosimilars Act Oppose Physician-Owned Hospital restrictions in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures H.R. 756/ S.660 - Support National Pain Care Policy Act of 2009 Oppose use of comparative effectiveness research to determine health care coverage or reimbursement decisions Support Health IT funding and standards Support Hagen/Enzi/Hatch Amendment to S. 325 Support HR 1894 and S. 769 Support Eshoo/Barton Amendment on biosimilars (to H.R. 3200) in House Energy and Commerce Committee Support increased Osteoporosis screening funds in health care reform bills Support request for House Oversight Committee hearings on prostate cancer, additional efforts to screen for and treat Oppose the establishment of a "Super MedPAC" Commission empowered to cut Medicare payments and benefits Oppose the Medicare cuts included in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures Oppose Senate Amendment 2793 Support McCain Motion to Recommit H.R. 3590 with instructions to remove all Medicare cuts Support Senate Amendment 2942 Support H.R. 3790 Support H.R. 2115 Support patient-centered comparative effectiveness research language passed by the Senate in H.R. 3590 Support 340B Federal Drug Discount Program purchasing provisions passed by the House and Senate in H.R. 3590 Oppose all efforts to shorten the 12-year exclusivity period provided (in both the House and Senate health care reform bills) for the original biologic drug as it pertains to a safe pathway for biosimilar "follow-on" drugs Support "Specialty Tier" pricing relief in Medicare Part D Drug Plans and in CMS rulemaking regarding those plans. Support increased funding to address the growing national burden of arthritis, including intervention and prevention plans. Support Efforts to Eliminate "Lifetime Caps" on health insurance benefits. Support Part D Medicare Coverage Gap Discount Program "draft guidance" to improve the program for beneficiaries. Oppose Recess Appointment of Dr. Donald Berwick as CMS Administrator. Support expanded screening for Osteoporosis for both women and men under new coverage rules. Support nomination of Peter Pitts for the Patient-Centered Outcomes Research Institute Board of Governors. Support Medicare reimbursement for Provenge to treat prostate cancer. Support the most stringent and rigorous testing of biosimilars that would or could be used as replacements for the original, innovator biologic drugs. Support the Council for American Medical Innovation comments to The National Commission on Fiscal Responsibility and Reform regarding the continuing need for spending to promote medical innovation to save lives and money. Support the Partnership to Fight Chronic Disease response to the Agency for Healthcare Research and Quality request for feedback on the National Quality Strategy and Plan development in regards to the Affordable Care Act.

Client expense: Not reported · Firm income: $13,310

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office

S 756, Prostate Research Imaging and Men's Education Act S 301, Physician Payments Sunshine Act of 2009 HR 759, FDA Globalization Act HR 3652, Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009 S 1695 Wired for Healthcare Act S 391, Healthy Americans Act S 391 HR 1346, Medical Device Safety Act of 2009 S 540, Medical Device Safety Act of 2009 Colorectal Cancer Prevention Early Detection and Treatment Act of 2009 Access to Medical Imaging HR 1894, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 HR 3200, America's Affordable Health Choices Act HR 3138 Physician Payments Sunshine Act HR 2502, Comparative Effectiveness Research Act of 2009 S 1213, Patient Centered Outcomes Research Act of 2009 S 1131, Independence at Home Act of 2009 HR 2962, Integrity in Medicare Advanced Diagnostic Imaging Act of 2009 HR 3276, American Medical Isotopes Production Act of 2009 HR 3200, America's Affordable Health Choices Act of 2009 S 1679, Affordable Health Choices Act S 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 S 1100, Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 Medical Imaging Appropriateness Criteria Medical Device Fees Comparative Effectiveness Research Health Information Technology Healthcare Reform MedPAC Reform Mammography Guidelines HR 3962, Affordable Healthcare for America Act HR 3590, Patient Protection and Affordable Care Act HR 4872, Healthcare and Education Affordability Reconciliation Act of 2010 USPSTF Transparency HR 5461, Virtual Screening for Colorectal Cancer Act of 2010 HR 1213, Screening Abdominal Aortic Aneurysms Very Efficiently Act of 2009 Labor, HHS Appropriations 510(k) REform Patient Safety Organizations S 3737, Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009 S 1451, FAA Air Transportation Modernization and Safety Improvement Act

Client expense: $9,280,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

S 756, Prostate Research Imaging and Men's Education Act S 301, Physician Payments Sunshine Act of 2009 HR 759, FDA Globalization Act HR 3652, Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009 S 1695 Wired for Healthcare Act S 391, Healthy Americans Act S 391 HR 1346, Medical Device Safety Act of 2009 S 540, Medical Device Safety Act of 2009 Colorectal Cancer Prevention Early Detection and Treatment Act of 2009 Access to Medical Imaging HR 1894, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 HR 3200, America's Affordable Health Choices Act HR 3138 Physician Payments Sunshine Act HR 2502, Comparative Effectiveness Research Act of 2009 S 1213, Patient Centered Outcomes Research Act of 2009 S 1131, Independence at Home Act of 2009 HR 2962, Integrity in Medicare Advanced Diagnostic Imaging Act of 2009 HR 3276, American Medical Isotopes Production Act of 2009 HR 3200, America's Affordable Health Choices Act of 2009 S 1679, Affordable Health Choices Act S 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 S 1100, Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 Medical Imaging Appropriateness Criteria Medical Device Fees Comparative Effectiveness Research Health Information Technology Healthcare Reform MedPAC Reform Mammography Guidelines HR 3962, Affordable Healthcare for America Act HR 3590, Patient Protection and Affordable Care Act HR 4872, Healthcare and Education Affordability Reconciliation Act of 2010 USPSTF Transparency HR 5461, Virtual Screening for Colorectal Cancer Act of 2010 HR 1213, Screening Abdominal Aortic Aneurysms Very Efficiently Act of 2009 Labor, HHS Appropriations

Client expense: $15,460,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

S 756, Prostate Research Imaging and Men's Education Act S 301, Physician Payments Sunshine Act of 2009 HR 759, FDA Globalization Act S 1695 Wired for Healthcare Act S 391, Healthy Americans Act S 391 HR 1346, Medical Device Safety Act of 2009 S 540, Medical Device Safety Act of 2009 Colorectal Cancer Prevention Early Detection and Treatment Act of 2009 Access to Medical Imaging HR 1894, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 HR 3200, America's Affordable Health Choices Act AAA Screening Legislation HR 3138 Physician Payments Sunshine Act HR 2502, Comparative Effectiveness Research Act of 2009 S 1213, Patient Centered Outcomes Research Act of 2009 S1131, Independence at Home Act of 2009 HR 2962, Integrity in Medicare Advanced Diagnostic Imaging Act of 2009 HR 3276, American Medical Isotopes Production Act of 2009 HR 3200, America's Affordable Health Choices Act of 2009 S 1679, Affordable Health Choices Act S 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 S 1100, Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 Medical Imaging Appropriateness Criteria Medical Device Fees Comparative Effectiveness Research Medicare Coverage of CT Colonography Health Information Technology Healthcare Reform MedPAC Reform Mammography Guidelines HR 3962, Affordable Healthcare for America Act HR 3590, Patient Protection and Affordable Care Act HR 4872, Healthcare and Education Affordability Reconciliation Act of 2010 USPSTF Transparency

Client expense: $7,310,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 HR 4190, S 2828, Endocrine Disruption Prevention Act of 2009 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S 3209, Safe Chemicals Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010 HR 4190, S 2828, Endocrine Disruption Prevention Act of 2009 HR 5210, Endocrine Disrupter Screening Enhancement Act of 2010 S 3209, Safe Chemicals Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

House, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Draft Legislation, FY11. S.3686, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2011. H.R. 1210, Arthritis Prevention, Control, and Cure Act of 2009. S. 984, Arthritis Prevention, Control, and Cure Act of 2009. H.R. 1894, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009. S. 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009. S. 3653, Health Care Bureaucrats Elimination Act. Medicare Physician Payment Reform Act of 2009, (P.L. 111-141). Patient Protection and Affordable Care Act, (P.L. 111-148). Monitor federal issues and legislation associated with health care policy.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1548 - Pathway for Biosimilars Act Oppose Physician-Owned Hospital restrictions in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures H.R. 756/ S.660 - Support National Pain Care Policy Act of 2009 Oppose use of comparative effectiveness research to determine health care coverage or reimbursement decisions Support Health IT funding and standards Support Hagen/Enzi/Hatch Amendment to S. 325 Support HR 1894 and S. 769 Support Eshoo/Barton Amendment on biosimilars (to H.R. 3200) in House Energy and Commerce Committee Support increased Osteoporosis screening funds in health care reform bills Support request for House Oversight Committee hearings on prostate cancer, additional efforts to screen for and treat Oppose the establishment of a "Super MedPAC" Commission empowered to cut Medicare payments and benefits Oppose the Medicare cuts included in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures Oppose Senate Amendment 2793 Support McCain Motion to Recommit H.R. 3590 with instructions to remove all Medicare cuts Support Senate Amendment 2942 Support H.R. 3790 Support H.R. 2115 Support patient-centered comparative effectiveness research language passed by the Senate in H.R. 3590 Support 340B Federal Drug Discount Program purchasing provisions passed by the House and Senate in H.R. 3590 Oppose all efforts to shorten the 12-year exclusivity period provided (in both the House and Senate health care reform bills) for the original biologic drug as it pertains to a safe pathway for biosimilar "follow-on" drugs Support "Specialty Tier" pricing relief in Medicare Part D Drug Plans and in CMS rulemaking regarding those plans. Support increased funding to address the growing national burden of arthritis, including intervention and prevention plans. Support Efforts to Eliminate "Lifetime Caps" on health insurance benefits. Support Part D Medicare Coverage Gap Discount Program "draft guidance" to improve the program for beneficiaries. Oppose Recess Appointment of Dr. Donald Berwick as CMS Administrator. Support expanded screening for Osteoporosis for both women and men under new coverage rules. Support nomination of Peter Pitts for the Patient-Centered Outcomes Research Institute Board of Governors.

Client expense: $176,190 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R. 3590 (111-148); H.R. 4872 (PL-111-152); H.R. 3962;

Client expense: $110,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; Implementation of P.L. 111-148 - Patient Protection and Affordable Care Act (DXA testing; End Stage Renal Disease); and P.L. 111-152- Health Care and Education Reconciliation Act (DXA testing; End Stage Renal Disease)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; Implementation of P.L. 111-148 - Patient Protection and Affordable Care Act (DXA testing; End Stage Renal Disease); and P.L. 111-152- Health Care and Education Reconciliation Act (DXA testing; End Stage Renal Disease)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1548 - Pathway for Biosimilars Act Oppose Physician-Owned Hospital restrictions in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures H.R. 756/ S.660 - Support National Pain Care Policy Act of 2009 Oppose use of comparative effectiveness research to determine health care coverage or reimbursement decisions Support Health IT funding and standards Support Hagen/Enzi/Hatch Amendment to S. 325 Support HR 1894 and S. 769 Support Eshoo/Barton Amendment on biosimilars (to H.R. 3200) in House Energy and Commerce Committee Support increased Osteoporosis screening funds in health care reform bills Support request for House Oversight Committee hearings on prostate cancer, additional efforts to screen for and treat Oppose the establishment of a "Super MedPAC" Commission empowered to cut Medicare payments and benefits Oppose the Medicare cuts included in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures Oppose Senate Amendment 2793 Support McCain Motion to Recommit H.R. 3590 with instructions to remove all Medicare cuts Support Senate Amendment 2942 Support H.R. 3790 Support H.R. 2115 Support patient-centered comparative effectiveness research language passed by the Senate in H.R. 3590 Support 340B Federal Drug Discount Program purchasing provisions passed by the House and Senate in H.R. 3590 Oppose all efforts to shorten the 12-year exclusivity period provided (in both the House and Senate health care reform bills) for the original biologic drug as it pertains to a safe pathway for biosimilar "follow-on" drugs Support "Specialty Tier" pricing relief in Medicare Part D Drug Plans and in CMS rulemaking regarding those plans. Support increased funding to address the growing national burden of arthritis, including intervention and prevention plans. Support Efforts to Eliminate "Lifetime Caps" on health insurance benefits. Support Part D Medicare Coverage Gap Discount Program "draft guidance" to improve the program for beneficiaries. Oppose Recess Appointment of Dr. Donald Berwick as CMS Administrator. Support expanded screening for Osteoporosis for both women and men under new coverage rules. Support nomination of Peter Pitts for the Patient-Centered Outcomes Research Institute Board of Governors.

Client expense: Not reported · Firm income: $13,695

Government targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R. 3590 (111-148); H.R. 4872 (PL-111-152); H.R. 3962;

Client expense: $65,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1548 - Pathway for Biosimilars Act Oppose Physician-Owned Hospital restrictions in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures H.R. 756/ S.660 - Support National Pain Care Policy Act of 2009 Oppose use of comparative effectiveness research to determine health care coverage or reimbursement decisions Support Health IT funding and standards Support Hagen/Enzi/Hatch Amendment to S. 325 Support HR 1894 and S. 769 Support Eshoo/Barton Amendment on biosimilars (to H.R. 3200) in House Energy and Commerce Committee Support increased Osteoporosis screening funds in health care reform bills Support request for House Oversight Committee hearings on prostate cancer, additional efforts to screen for and treat Oppose the establishment of a "Super MedPAC" Commission empowered to cut Medicare payments and benefits Oppose the Medicare cuts included in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures Oppose Senate Amendment 2793 Support McCain Motion to Recommit H.R. 3590 with instructions to remove all Medicare cuts Support Senate Amendment 2942 Support H.R. 3790 Support H.R. 2115 Support patient-centered comparative effectiveness research language passed by the Senate in H.R. 3590 Support 340B Federal Drug Discount Program purchasing provisions passed by the House and Senate in H.R. 3590 Oppose all efforts to shorten the 12-year exclusivity period provided (in both the House and Senate health care reform bills) for the original biologic drug as it pertains to a safe pathway for biosimilar "follow-on" drugs Support "Specialty Tier" pricing relief in Medicare Part D Drug Plans and in CMS rulemaking regarding those plans. Support increased funding to address the growing national burden of arthritis, including intervention and prevention plans. Support Efforts to Eliminate "Lifetime Caps" on health insurance benefits. Support Part D Medicare Coverage Gap Discount Program "draft guidance" to improve the program for beneficiaries. Oppose Recess Appointment of Dr. Donald Berwick as CMS Administrator.

Client expense: $172,523 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; Implementation of P.L. 111-148 - Patient Protection and Affordable Care Act (DXA testing; End Stage Renal Disease); and P.L. 111-152- Health Care and Education Reconciliation Act (DXA testing; End Stage Renal Disease)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; Implementation of P.L. 111-148 - Patient Protection and Affordable Care Act (DXA testing; End Stage Renal Disease); and P.L. 111-152- Health Care and Education Reconciliation Act (DXA testing; End Stage Renal Disease)

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 756, Prostate Research Imaging and Men's Education Act S 301, Physician Payments Sunshine Act of 2009 HR 759, FDA Globalization Act HR 3652, Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2009 S 1695 Wired for Healthcare Act S 391, Healthy Americans Act S 391 HR 1346, Medical Device Safety Act of 2009 S 540, Medical Device Safety Act of 2009 Colorectal Cancer Prevention Early Detection and Treatment Act of 2009 Access to Medical Imaging HR 1894, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 HR 3200, America's Affordable Health Choices Act HR 3138 Physician Payments Sunshine Act HR 2502, Comparative Effectiveness Research Act of 2009 S 1213, Patient Centered Outcomes Research Act of 2009 S 1131, Independence at Home Act of 2009 HR 2962, Integrity in Medicare Advanced Diagnostic Imaging Act of 2009 HR 3276, American Medical Isotopes Production Act of 2009 HR 3200, America's Affordable Health Choices Act of 2009 S 1679, Affordable Health Choices Act S 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 S 1100, Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 Medical Imaging Appropriateness Criteria Medical Device Fees Comparative Effectiveness Research Health Information Technology Healthcare Reform MedPAC Reform Mammography Guidelines HR 3962, Affordable Healthcare for America Act HR 3590, Patient Protection and Affordable Care Act HR 4872, Healthcare and Education Affordability Reconciliation Act of 2010 USPSTF Transparency HR 5461, Virtual Screening for Colorectal Cancer Act of 2010 HR 1213, Screening Abdominal Aortic Aneurysms Very Efficiently Act of 2009 Labor, HHS Appropriations

Client expense: $8,300,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.4213, American Workers, State, and Business Relief Act of 2010. H.R. 3400, Empowering Patients First Act. H.R. 3970, Medical Rights and Reform Act of 2009. H.R. 1210, Arthritis Prevention, Control, and Cure Act of 2009. S. 984, Arthritis Prevention, Control, and Cure Act of 2009. H.R. 1894, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009. S. 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009. H.R. 4273, Pediatric Workforce Investment Act. S. 1206, Pediatric Workforce Investment Act. Medicare Physician Payment Reform Act of 2009, (P.L. 111-142). Patient Protection and Affordable Care Act, (P.L. 111-148). Health Care and Education Reconciliation Act of 2010, (P.L. 111-152). Affordable Health Care for America Act, (P.L. 111-192). Monitor federal issues and legislation associated with health care policy.

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1548 - Pathway for Biosimilars Act Oppose Physician-Owned Hospital restrictions in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures H.R. 756/ S.660 - Support National Pain Care Policy Act of 2009 Oppose use of comparative effectiveness research to determine health care coverage or reimbursement decisions Support Health IT funding and standards Support Hagen/Enzi/Hatch Amendment to S. 325 Support HR 1894 and S. 769 Support Eshoo/Barton Amendment on biosimilars (to H.R. 3200) in House Energy and Commerce Committee Support increased Osteoporosis screening funds in health care reform bills Support request for House Oversight Committee hearings on prostate cancer, additional efforts to screen for and treat Oppose the establishment of a "Super MedPAC" Commission empowered to cut Medicare payments and benefits Oppose the Medicare cuts included in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures Oppose Senate Amendment 2793 Support McCain Motion to Recommit H.R. 3590 with instructions to remove all Medicare cuts Support Senate Amendment 2942 Support H.R. 3790 Support H.R. 2115 Support patient-centered comparative effectiveness research language passed by the Senate in H.R. 3590 Support 340B Federal Drug Discount Program purchasing provisions passed by the House and Senate in H.R. 3590 Oppose all efforts to shorten the 12-year exclusivity period provided (in both the House and Senate health care reform bills) for the original biologic drug as it pertains to a safe pathway for biosimilar "follow-on" drugs Support "Specialty Tier" pricing relief in Medicare Part D Drug Plans and in CMS rulemaking regarding those plans. Support increased funding to address the growing national burden of arthritis, including intervention and prevention plans. Support Efforts to Eliminate "Lifetime Caps" on health insurance benefits. Support Part D Medicare Coverage Gap Discount Program "draft guidance" to improve the program for beneficiaries. Oppose Recess Appointment of Dr. Donald Berwick as CMS Administrator.

Client expense: Not reported · Firm income: $14,520

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R. 1548 - Pathway for Biosimilars Act Oppose Physician-Owned Hospital restrictions in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures H.R. 756/ S.660 - Support National Pain Care Policy Act of 2009 Oppose use of comparative effectiveness research to determine health care coverage or reimbursement decisions Support Health IT funding and standards Support Hagen/Enzi/Hatch Amendment to S. 325 Support HR 1894 and S. 769 Support Eshoo/Barton Amendment on biosimilars (to H.R. 3200) in House Energy and Commerce Committee Support increased Osteoporosis screening funds in health care reform bills Support request for House Oversight Committee hearings on prostate cancer, additional efforts to screen for and treat Oppose the establishment of a "Super MedPAC" Commission empowered to cut Medicare payments and benefits Oppose the Medicare cuts included in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures Oppose Senate Amendment 2793 Support McCain Motion to Recommit H.R. 3590 with instructions to remove all Medicare cuts Support Senate Amendment 2942 Support H.R. 3790 Support H.R. 2115 Support patient-centered comparative effectiveness research language passed by the Senate in H.R. 3590 Support 340B Federal Drug Discount Program purchasing provisions passed by the House and Senate in H.R. 3590 Oppose all efforts to shorten the 12-year exclusivity period provided (in both the House and Senate health care reform bills) for the original biologic drug as it pertains to a safe pathway for biosimilar "follow-on" drugs Support "Specialty Tier" pricing relief in Medicare Part D Drug Plans and in CMS rulemaking regarding those plans. Support increased funding to address the growing national burden of arthritis, including intervention and prevention plans.

Client expense: $175,137 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

H.R.1894 and S 769: Medicare Fracture Prevention & Osteoporosis Testing Act; H.R. 3590 (111-148); H.R. 4872 (PL-111-152); H.R. 3962;

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1548 - Pathway for Biosimilars Act Oppose Physician-Owned Hospital restrictions in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures H.R. 756/ S.660 - Support National Pain Care Policy Act of 2009 Oppose use of comparative effectiveness research to determine health care coverage or reimbursement decisions Support Health IT funding and standards Support Hagen/Enzi/Hatch Amendment to S. 325 Support HR 1894 and S. 769 Support Eshoo/Barton Amendment on biosimilars (to H.R. 3200) in House Energy and Commerce Committee Support increased Osteoporosis screening funds in health care reform bills Support request for House Oversight Committee hearings on prostate cancer, additional efforts to screen for and treat Oppose the establishment of a "Super MedPAC" Commission empowered to cut Medicare payments and benefits Oppose the Medicare cuts included in H.R. 3200, H.R. 3962, H.R. 3590, and all health care reform measures Oppose Senate Amendment 2793 Support McCain Motion to Recommit H.R. 3590 with instructions to remove all Medicare cuts Support Senate Amendment 2942 Support H.R. 3790 Support H.R. 2115 Support patient-centered comparative effectiveness research language passed by the Senate in H.R. 3590 Support 340B Federal Drug Discount Program purchasing provisions passed by the House and Senate in H.R. 3590 Oppose all efforts to shorten the 12-year exclusivity period provided (in both the House and Senate health care reform bills) for the original biologic drug as it pertains to a safe pathway for biosimilar "follow-on" drugs Support "Specialty Tier" pricing relief in Medicare Part D Drug Plans and in CMS rulemaking regarding those plans. Support increased funding to address the growing national burden of arthritis, including intervention and prevention plans.

Client expense: Not reported · Firm income: $12,701

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office

Medicare Coverage and Reimbursement Issues HR 1894 and S 769, Medicare Fracture and Osteoporosis Testing Act of 2009 (DXA testing) HR 3590, Patient Protection and Affordable Care Act (End Stage Renal Disease; Medicaid Drug Rebate Program; Medicare Part D Co-pay Assistance, Independent Payment and Advisory Board) HR 4872, Health Care and Education Reconciliation Act (End Stage Renal Disease, Medicaid Drug Rebate Program, Independent Payment and Advisory Board)

Client expense: $3,070,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S 756, Prostate Research Imaging and Men's Education Act S 301, Physician Payments Sunshine Act of 2009 HR 759, FDA Globalization Act S 1695 Wired for Healthcare Act S 391, Healthy Americans Act S 391 HR 1346, Medical Device Safety Act of 2009 S 540, Medical Device Safety Act of 2009 Colorectal Cancer Prevention Early Detection and Treatment Act of 2009 Access to Medical Imaging HR 1894, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 HR 3200, America's Affordable Health Choices Act AAA Screening Legislation HR 3138 Physician Payments Sunshine Act HR 2502, Comparative Effectiveness Research Act of 2009 S 1213, Patient Centered Outcomes Research Act of 2009 S1131, Independence at Home Act of 2009 HR 2962, Integrity in Medicare Advanced Diagnostic Imaging Act of 2009 HR 3276, American Medical Isotopes Production Act of 2009 HR 3200, America's Affordable Health Choices Act of 2009 S 1679, Affordable Health Choices Act S 769, Medicare Fracture Prevention and Osteoporosis Testing Act of 2009 S 1100, Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 Medical Imaging Appropriateness Criteria Medical Device Fees Comparative Effectiveness Research Medicare Coverage of CT Colonography Health Information Technology Healthcare Reform MedPAC Reform Mammography Guidelines HR 3962, Affordable Healthcare for America Act HR 3590, Patient Protection and Affordable Care Act HR 4872, Healthcare and Education Affordability Reconciliation Act of 2010 USPSTF Transparency

Client expense: $7,140,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Reserve System, Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Interior, Dept of (DOI), Justice, Dept of (DOJ), Labor, Dept of (DOL), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

Medicare coverage and reimbursement, including H.R. 1894, H.R. 3590 - Patient Protection and Affordable Care Act, and related legislation (provisions related to Medicare coverage and reimbursement for DXA testing).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act (DXA testing coverage/reimbursement, End Stage Renal Disease).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act (DXA testing coverage/reimbursement, End Stage Renal Disease).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act (DXA testing coverage/reimbursement, End Stage Renal Disease).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act (DXA testing coverage/reimbursement, End Stage Renal Disease).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act (DXA testing coverage/reimbursement, End Stage Renal Disease).

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare Coverage and Reimbursement issues; S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 3590 - Patient Protection and Affordable Care Act; and HR 4872 - Health Care and Education Reconciliation Act.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1894, S. 769, the Medicare Fracture Prevention and Osteoporosis Testing Act Minority Health Disparities (obesity and diabetes) Endocrine Disruptors Issues H. R. 3200, America's Affordable Health Choices Act of 2009, Osteoporosis prevention provisions, provider workforce provisions S. 1796, Americas Healthy Future Act of 2009, Osteoporosis prevention provisions, provider workforce provisions H.R. 3962, Affordable Health Care for America Act, Osteoporosis prevention provisions, provider workforce provisions H.R. 3590, The Patient Protection and Affordable Care Act, Osteoporosis prevention provisions, provider workforce provisions HR 4872, Health Care and Education Reconciliation Act of 2010

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1894 and S. 769: Medicare Fracture Prev. and Osteoporosis Testing Act; H.R. 583; S. 1042; H.R. 3200: America's Affordable Health Choice Act of 2009; S. 1679: Affordable Health Choice Act; America's Healthy Future Act; Patient Protection & Affordable Care Act (H.R. 3590/Pub.L.No.111-148) and Affordable Health Care for America Act (H.R. 3962).

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE